CXCL11 Signaling in the Tumor Microenvironment

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Chemokine CXCL11, binding to CXCR3 and CXCR7 receptors, is increasingly significant in tumor research.
• The tumor microenvironment (TME) is a complex ecosystem where immune cells and signaling molecules interact to influence tumor progression.

Purpose of the Study:

• To review the current evidence on the role of CXCL11's immune response within the tumor microenvironment (TME).
• To explore the therapeutic potential of CXCL11 as an adjuvant in cancer treatment.

Main Methods:

• Literature review and synthesis of existing research on CXCL11 function in cancer.
• Analysis of CXCL11's diverse biological activities, including its impact on angiogenesis, cell proliferation, invasion, and immune cell migration.
• Discussion of CXCL11's role in modulating macrophage polarization and its interaction with fibroblast-directed carcinoma invasion.

Main Results:

• CXCL11 exhibits multifaceted roles in the TME, including inhibition of angiogenesis and suppression of M2 macrophage polarization.
• CXCL11 influences cancer cell proliferation, invasion, and the migration of specific immune cells.
• CXCL11 demonstrates potential as an adjuvant therapy, enhancing the efficacy of mainstream anti-cancer treatments.

Conclusions:

• CXCL11 is a critical modulator of the immune response within the tumor microenvironment, impacting multiple aspects of tumor biology.
• Targeted therapies involving CXCL11 hold promise for improving current anti-cancer strategies, though challenges remain.
• Further research into CXCL11-targeted therapies is warranted to overcome existing challenges and optimize clinical application.